Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 1.33 is in line with its estimated 5-year average of 1.28, near the low end of its estimated 5-year range (0.66–8.94).
As of 2026-10-06T14:10:31.422Z. 46.38% above its estimated 12-month average of 0.91.
Calculation as of: 2026-10-06T14:10:31.422Z.
Quote observation: 2026-10-06T14:10:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3dded1d9c7c97f6604bba9f83d6a77d690042e17e53b2ba4f54e500de5eb4a7b
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
1.33
PS RATIO AVG TTM
0.91
PS RATIO AVG 3Y
1.09
PS RATIO AVG 5Y
1.28
PS RATIO AVG 10Y
22.97
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+46.38%
CURRENT VS 3Y AVG
+21.56%
CURRENT VS 5Y AVG
+4.20%
CURRENT VS 10Y AVG
-94.21%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.04
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
-67.08%
vs the sector median at left
Market Cap
$285.18M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$285.98M
PS Ratio
11.21
TTM Avg
341.11
3Y Avg
260.22
5Y Avg
137.39
Market Cap
$262.75M
PS Ratio
N/A
TTM Avg
8336935.98
3Y Avg
3234328.97
5Y Avg
2173022.38
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurora Cannabis Inc. (ACB) | $276.26M | 1.33 | 0.91 | 1.09 | 1.28 |
| Fate Therapeutics, Inc. (FATE)vs › | $278.58M | 42.92 | 30.89 | 23.00 | 28.64 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $272.91M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.16M | N/A | 6.36 | 62.99 | 58.72 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $285.18M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.98M | 11.21 | 341.11 | 260.22 | 137.39 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $266.17M | N/A | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $287.76M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $262.75M | N/A | 8336935.98 | 3234328.97 | 2173022.38 |
| Anika Therapeutics, Inc. (ANIK)vs › | $261.90M | 2.17 | 1.86 | 1.92 | 2.22 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
Reported statement amounts were converted from CAD to USD using the stored FMP exchange-rate calculation.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $64,882,788 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q3 FY2026Period ended 2025-12-31 | $68,589,886 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-04 |
| Q4 FY2026Period ended 2026-03-31 | $27,398,928 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-11 |
| Q1 FY2027Period ended 2026-06-30 | $47,578,621 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $208,450,224 |
Current P/S: $276,255,572 market capitalization ÷ $208,450,224 TTM revenue = 1.33x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:10:20.000Z. Latest revenue period ended 2026-06-30.
At 1.33, P/S is below its estimated 11-year median — higher than 27% of readings in its estimated 11-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 11-year low
0.66
median
5.62
estimated 11-year high
444.19
P/S Ratio
1.33
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 1.32 |
| 2026-10-02 | 1.16 |
| 2026-10-01 | 1.15 |
| 2026-09-30 | 1.15 |
| 2026-09-29 | 1.19 |
| 2026-09-28 | 1.21 |
| 2026-09-25 | 1.21 |
| 2026-09-24 | 1.23 |
| 2026-09-23 | 1.25 |
| 2026-09-22 | 1.26 |
| 2026-09-21 | 1.19 |
| 2026-09-18 | 1.15 |
| 2026-09-17 | 1.14 |
| 2026-09-16 | 1.13 |
| 2026-09-15 | 1.13 |
| 2026-09-14 | 1.13 |
| 2026-09-11 | 1.11 |
| 2026-09-10 | 1.10 |
| 2026-09-09 | 1.15 |
| 2026-09-08 | 1.15 |
| 2026-09-04 | 1.17 |
| 2026-09-03 | 1.15 |
| 2026-09-02 | 1.19 |
| 2026-09-01 | 1.20 |
| 2026-08-31 | 1.20 |
| 2026-08-28 | 1.19 |
| 2026-08-27 | 1.19 |
| 2026-08-26 | 1.18 |
| 2026-08-25 | 1.19 |
| 2026-08-24 | 1.17 |
| 2026-08-21 | 1.17 |
| 2026-08-20 | 1.13 |
| 2026-08-19 | 1.16 |
| 2026-08-18 | 1.09 |
| 2026-08-17 | 1.07 |
| 2026-08-14 | 1.09 |
| 2026-08-13 | 1.12 |
| 2026-08-12 | 1.13 |
| 2026-08-11 | 1.03 |
| 2026-08-10 | 0.86 |
| 2026-08-07 | 0.88 |
| 2026-08-06 | 0.88 |
| 2026-08-05 | 0.74 |
| 2026-08-04 | 0.72 |
| 2026-08-03 | 0.72 |
| 2026-07-31 | 0.71 |
| 2026-07-30 | 0.72 |
| 2026-07-29 | 0.70 |
| 2026-07-28 | 0.69 |
| 2026-07-27 | 0.70 |
| 2026-07-24 | 0.68 |
| 2026-07-23 | 0.69 |
| 2026-07-22 | 0.68 |
| 2026-07-21 | 0.68 |
| 2026-07-20 | 0.66 |
| 2026-07-17 | 0.67 |
| 2026-07-16 | 0.66 |
| 2026-07-15 | 0.68 |
| 2026-07-14 | 0.68 |
| 2026-07-13 | 0.68 |
| 2026-07-10 | 0.69 |
| 2026-07-09 | 0.69 |
| 2026-07-08 | 0.68 |
| 2026-07-07 | 0.68 |
| 2026-07-06 | 0.69 |
| 2026-07-02 | 0.72 |
| 2026-07-01 | 0.72 |
| 2026-06-30 | 0.71 |
| 2026-06-29 | 0.73 |
| 2026-06-26 | 0.72 |
| 2026-06-25 | 0.70 |
| 2026-06-24 | 0.72 |
| 2026-06-23 | 0.73 |
| 2026-06-22 | 0.73 |
| 2026-06-18 | 0.75 |
| 2026-06-17 | 0.74 |
| 2026-06-16 | 0.76 |
| 2026-06-15 | 0.75 |
| 2026-06-12 | 0.77 |
| 2026-06-11 | 0.68 |
| 2026-06-10 | 0.72 |
| 2026-06-09 | 0.74 |
| 2026-06-08 | 0.75 |
| 2026-06-05 | 0.74 |
| 2026-06-04 | 0.77 |
| 2026-06-03 | 0.75 |
| 2026-06-02 | 0.77 |
| 2026-06-01 | 0.80 |
| 2026-05-29 | 0.79 |
| 2026-05-28 | 0.81 |
| 2026-05-27 | 0.76 |
| 2026-05-26 | 0.76 |
| 2026-05-22 | 0.76 |
| 2026-05-21 | 0.78 |
| 2026-05-20 | 0.76 |
| 2026-05-19 | 0.72 |
| 2026-05-18 | 0.72 |
| 2026-05-15 | 0.73 |
| 2026-05-14 | 0.74 |
| 2026-05-13 | 0.73 |
| 2026-05-12 | 0.74 |
| 2026-05-11 | 0.75 |
| 2026-05-08 | 0.75 |
| 2026-05-07 | 0.75 |
| 2026-05-06 | 0.78 |
| 2026-05-05 | 0.76 |
| 2026-05-04 | 0.75 |
| 2026-05-01 | 0.76 |
| 2026-04-30 | 0.76 |
| 2026-04-29 | 0.72 |
| 2026-04-28 | 0.75 |
| 2026-04-27 | 0.77 |
| 2026-04-24 | 0.74 |
| 2026-04-23 | 0.72 |
| 2026-04-22 | 0.83 |
| 2026-04-21 | 0.78 |
| 2026-04-20 | 0.82 |
| 2026-04-17 | 0.80 |
| 2026-04-16 | 0.79 |
| 2026-04-15 | 0.81 |
| 2026-04-14 | 0.77 |
| 2026-04-13 | 0.76 |
| 2026-04-10 | 0.75 |
| 2026-04-09 | 0.76 |
| 2026-04-08 | 0.75 |
| 2026-04-07 | 0.74 |
| 2026-04-06 | 0.76 |
| 2026-04-02 | 0.76 |
| 2026-04-01 | 0.74 |
| 2026-03-31 | 0.72 |
| 2026-03-30 | 0.68 |
| 2026-03-27 | 0.70 |
| 2026-03-26 | 0.73 |
| 2026-03-25 | 0.75 |
| 2026-03-24 | 0.73 |
| 2026-03-23 | 0.73 |
| 2026-03-20 | 0.72 |
| 2026-03-19 | 0.74 |
| 2026-03-18 | 0.76 |
| 2026-03-17 | 0.77 |
| 2026-03-16 | 0.76 |
| 2026-03-13 | 0.75 |
| 2026-03-12 | 0.77 |
| 2026-03-11 | 0.79 |
| 2026-03-10 | 0.78 |
| 2026-03-09 | 0.77 |
| 2026-03-06 | 0.77 |
| 2026-03-05 | 0.77 |
| 2026-03-04 | 0.80 |
| 2026-03-03 | 0.76 |
| 2026-03-02 | 0.81 |
| 2026-02-27 | 0.84 |
| 2026-02-26 | 0.85 |
| 2026-02-25 | 0.84 |
| 2026-02-24 | 0.83 |
| 2026-02-23 | 0.80 |
| 2026-02-20 | 0.83 |
| 2026-02-19 | 0.82 |
| 2026-02-18 | 0.78 |
| 2026-02-17 | 0.79 |
| 2026-02-13 | 0.78 |
| 2026-02-12 | 0.74 |
| 2026-02-11 | 0.76 |
| 2026-02-10 | 0.78 |
| 2026-02-09 | 0.79 |
| 2026-02-06 | 0.76 |
| 2026-02-05 | 0.73 |
| 2026-02-04 | 0.82 |
| 2026-02-03 | 0.89 |
| 2026-02-02 | 0.86 |
| 2026-01-30 | 0.89 |
| 2026-01-29 | 0.92 |
| 2026-01-28 | 0.95 |
| 2026-01-27 | 0.97 |
| 2026-01-26 | 0.95 |
| 2026-01-23 | 0.97 |
| 2026-01-22 | 0.95 |
| 2026-01-21 | 0.93 |
| 2026-01-20 | 0.91 |
| 2026-01-16 | 0.93 |
| 2026-01-15 | 0.93 |
| 2026-01-14 | 0.94 |
| 2026-01-13 | 0.93 |
| 2026-01-12 | 0.94 |
| 2026-01-09 | 0.93 |
| 2026-01-08 | 0.94 |
| 2026-01-07 | 0.93 |
| 2026-01-06 | 0.93 |
| 2026-01-05 | 0.94 |
| 2026-01-02 | 0.95 |
| 2025-12-31 | 0.93 |
| 2025-12-30 | 0.94 |
| 2025-12-29 | 0.95 |
| 2025-12-26 | 0.99 |
| 2025-12-24 | 1.00 |
| 2025-12-23 | 1.02 |
| 2025-12-22 | 1.03 |
| 2025-12-19 | 1.09 |
| 2025-12-18 | 1.18 |
| 2025-12-17 | 1.22 |
| 2025-12-16 | 1.21 |
| 2025-12-15 | 1.12 |
| 2025-12-12 | 1.19 |
| 2025-12-11 | 1.00 |
| 2025-12-10 | 0.99 |
| 2025-12-09 | 1.01 |
| 2025-12-08 | 0.98 |
| 2025-12-05 | 1.01 |
| 2025-12-04 | 1.00 |
| 2025-12-03 | 1.00 |
| 2025-12-02 | 0.98 |
| 2025-12-01 | 0.99 |
| 2025-11-28 | 1.01 |
| 2025-11-26 | 1.01 |
| 2025-11-25 | 0.98 |
| 2025-11-24 | 0.96 |
| 2025-11-21 | 0.92 |
| 2025-11-20 | 0.90 |
| 2025-11-19 | 0.94 |
| 2025-11-18 | 0.97 |
| 2025-11-17 | 0.94 |
| 2025-11-14 | 0.95 |
| 2025-11-13 | 0.96 |
| 2025-11-12 | 0.99 |
| 2025-11-11 | 1.00 |
| 2025-11-10 | 1.03 |
| 2025-11-07 | 1.00 |
| 2025-11-06 | 0.96 |
| 2025-11-05 | 1.00 |
| 2025-11-04 | 1.02 |
| 2025-11-03 | 1.09 |
| 2025-10-31 | 1.11 |
| 2025-10-30 | 1.08 |
| 2025-10-29 | 1.11 |
| 2025-10-28 | 1.12 |
| 2025-10-27 | 1.14 |
| 2025-10-24 | 1.18 |
| 2025-10-23 | 1.14 |
| 2025-10-22 | 1.13 |
| 2025-10-21 | 1.15 |
| 2025-10-20 | 1.19 |
| 2025-10-17 | 1.17 |
| 2025-10-16 | 1.18 |
| 2025-10-15 | 1.26 |
| 2025-10-14 | 1.23 |
| 2025-10-13 | 1.21 |
| 2025-10-10 | 1.19 |
| 2025-10-09 | 1.38 |
| 2025-10-08 | 1.37 |
| 2025-10-07 | 1.38 |
| 2025-10-06 | 1.30 |
| 2025-10-03 | 1.27 |
| 2025-10-02 | 1.27 |
| 2025-10-01 | 1.28 |
| 2025-09-30 | 1.33 |
| 2025-09-29 | 1.40 |
| 2025-09-26 | 1.09 |
| 2025-09-25 | 1.11 |
| 2025-09-24 | 1.16 |
| 2025-09-23 | 1.13 |
Showing the most recent 260 of 2,643 data points. The chart above shows the full history.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.